- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Timothy Murphy: Strong Communication Is Necessary for Practices Stocking Multiple Biosimilars
With multiple biosimilars approved for a reference product and different payers preferring particular products, communication between the clinical pharmacy team and the managed care team is crucial, said Timothy Murphy, MD, FACP, medical oncologist/hematologist with Rocky Mountain Cancer Centers.
With multiple biosimilars approved for a reference product and different payers preferring particular products, communication between the clinical pharmacy team and the managed care team is crucial, said Timothy Murphy, MD, FACP, medical oncologist/hematologist with Rocky Mountain Cancer Centers.
Transcript
How are community oncology practices handling the challenge of stocking multiple biosimilars for the same reference product and balancing the needs of various payers?
Fortunately, those issues play to the power of community oncology, and particularly Rocky Mountain Cancer Centers. We have a strong clinical pharmacy team—they work very closely with our managed care team. To your point, some payers are now preferring a particular product vs another. In the old days, we could have one type of medication in that class, but now we're going to have to keep inventory with multiple.
That takes a strong pharmacy-led team. It takes strong education on the pharmacy techs. It takes strong leadership from the managed care team. That communication piece is vital. Once the physicians got buy-in—they trusted the process—I think we're well positioned to handle this transformation, which is happening in real time.
Balancing Cost and Quality in Oncology: A Value-Based Care Perspective
January 30th 2025Travis Brewer, vice president of payer and public health strategy/relations at Texas Oncology, shared that value-based oncology care can achieve both cost efficiency and high-quality outcomes through integrated multidisciplinary teams, flexible payment models, and targeted treatment approaches.
Read More
Unlocking Access: Exploring Mental Health Care Among Medicaid Managed Care Enrollees
January 23rd 2025On this episode of Managed Care Cast, we speak with the author of a study published in the January 2025 issue of The American Journal of Managed Care® to examine the association between quantitative network adequacy standards and mental health care access among adult Medicaid enrollees.
Listen
How FcRn Blockade Targets Myasthenia Gravis Autoantibodies
January 29th 2025In part 2 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the challenge inherent in treating adolescents who have the myasthenia gravis and how nipocalimab works via FcRn blockade to reduce the circulating autoantibodies that drive myasthenia gravis.
Read More
